Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exacerbation of Idiopathic Pulmonary Fibrosis”

14 trials

Showing 14 of 14 results

Large-scale testing (Phase 3)Looking for participantsNCT05674994
What this trial is testing

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-Joseph 110
Not applicableLooking for participantsNCT05842681
What this trial is testing

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assiut University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07299695
What this trial is testing

Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisAcute Exacerbation of Idiopathic Pulmonary Fibrosis
Argyrios Tzouvelekis 196
Not applicableUnknownNCT03584802
What this trial is testing

Therapeutic Plasma Exchange, Rituximab and IV Ig for Severe Acute Exacerbation of IPF Admitted in ICU

Who this might be right for
Exacerbation of Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 40
Not applicableStudy completedNCT04996303
What this trial is testing

Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER

Who this might be right for
Idiopathic Pulmonary Fibrosis With Acute Exacerbation
Yonsei University 100
Not applicableUnknownNCT06027372
What this trial is testing

Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Taipei Veterans General Hospital, Taiwan 70
Large-scale testing (Phase 3)Study completedNCT02739165
What this trial is testing

Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Asahi Kasei Pharma Corporation 74
Not applicableStudy completedNCT03979430
What this trial is testing

Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study

Who this might be right for
Acute ExacerbationIdiopathic Pulmonary FibrosisHome Spirometry
Heidelberg University 47
Not applicableLooking for participantsNCT04442711
What this trial is testing

Cohort of IPF Patients Experiencing an Exacerbation

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Gentofte, Copenhagen 50
Large-scale testing (Phase 3)Study completedNCT02460588
What this trial is testing

Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Not applicableActive Not RecruitingNCT05313672
What this trial is testing

Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
Roberto Tonelli 20
Not applicableUnknownNCT02509364
What this trial is testing

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Who this might be right for
Interstitial Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China 300
Not applicableLooking for participantsNCT06445686
What this trial is testing

Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Biosency 30
Testing effectiveness (Phase 2)Study completedNCT03286556
What this trial is testing

Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis, Acute Fatal Form
University of Alabama at Birmingham 51

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation